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Sunlnlal'y 
Bipotential  T/natural  killer  (NK)  progenitor  cells are destined  to  differentiate  mainly into  T 
cell receptor (TCR)ix[3 and TCR~/8 cells in a thymic microenvironment,  whereas extrathymi- 
cally they selectively develop into  NK cells.  The  exact environmental  conditions  that are re- 
quired  for differentiation  into  these three leukocyte populations  are largely unknown.  In this 
report,  we  have investigated  and  compared the  effect of interleukin  (IL)-15  and  IL-2 in this 
process.  The IL-15 receptor is composed of the y  and  [3 chains of the IL-2 receptor (IL-2Ry 
and  IL-2R[B)  and  of a  specific  ix  chain  (IL-15Rix).  Here,  it  is  shown  that  IL-15  mRNA  is 
mainly  expressed  in  thymic  epithelial  stromal  cells,  whereas  IL-2  mRNA  is  exclusively  ex- 
pressed  in  thymocytes.  IL-2R[B-expressing  cells  were  present  in  the  fetal  thymus  with  a 
CD25-CD44+FcyR+HSA-/l~  -  phenotype,  which  is  characteristic  of progenitor  ceils. 
These cells also expressed IL-15Rix messenger RNA.  Sorted  IL-2R[B+TCR -  cells differenti- 
ated into TCRixlB and TCR',/8 cells after transfer to alymphoid thymic lobes, whereas culture 
of the same sorted cells in cell suspension in the presence of IL-15 resulted in the generation of 
functional NK cells. This shows that IL-2R[~+TCR -  cells of the fetal thymus contain bipoten- 
tial T/NK  progenitors.  Addition  of low concentrations  of IL-15 to fetal thymic organ culture 
(FTOC)  resulted in an increase of all T  cell subpopulations.  The largest expansion occurred in 
the TCR',/8 compartment. In contrast, low concentrations oflL-2 did not result in a higher to- 
tal cell number and did not induce  outgrowth  of TCRy8  cells.  High concentrations  of IL-15 
blocked TCRix[~ development and shifted differentiation towards NK cells. Differentiation to- 
wards  TCR2r  cells  still proceeded.  High  concentrations  of IL-2 similarly induced  develop- 
ment into  NK  cells,  but  the  cell  number was fourfold lower  than  in  IL-15  cultures.  Impor- 
tantly, blocking of IL-2Rix in IL-2-treated FTOC  resulted in a drastic increase in cell number, 
indicating  that  IL-2Rix  negatively  regulates  cell  expansion.  Collectively,  these  experiments 
provide direct evidence that IL-15 and IL-2 differentially affect the differentiation  of bipoten- 
tial T/NK  progenitors. 
I 
L-15 is a novel cytokine that was originally cloned from 
CV-1/EBNA,  a simian kidney epithelial cell line (1). Al- 
though the amino acid sequence oflL-15 has no homology 
to IL-2, three-dimensional  modeling of IL-15 predicts that 
it is a four-helix bundle type cytokine (1), and thus IL-15 is 
a member of the same cytokine family as is IL-2 (2).  IL-15 
also  uses  components  of the  IL-2 receptor  (IL-2R):  both 
the [3 and "y chains of the IL-2R are required for binding and 
signal transduction  by this cytokine  (3).  In addition,  a spe- 
cific ix chain of the IL-15R has been identified.  This IL-15R 
ix chain  (IL-15Rix) 1 is structurally  similar to the  IL-2R ix 
chain,  but  with  only  limited  sequence  identity  (4).  The 
common use of the IL-2R [~ and y  chains by both IL-2 and 
IL-15 probably explains  the  finding  that  several biological 
*Abbreviations used in this paper: DP, CD4 and CD8 double positive; FD, 
fetal day; FTOC, fetal thymic organ culture; HPR.T, hypoxanthin phos- 
phoribosyltransferase; IL-1517,~, IL-15 receptor ot chain; RAG-l, recom- 
bination activating gene-1; I<T-PCR., reverse transcription PCR. 
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duction  of proliferation  of phytohemagglutinin-stimulated 
human peripheral  blood T  lymphocytes (1)  and induction 
of proliferation and differentiation of human B  ceils (5).  In 
addition, as is the case for IL-2, IL-15 is a selective chemo- 
attractant for human blood T lymphocytes (6) and is able to 
activate cytotoxic activity and cytokine production by hu- 
man NK cells  (7). 
Although several biological activities  of IL-15 and  IL-2 
are  overlapping,  there  are  some  differences.  It  has  been 
shown that production of GM-CSF by human NK cells  in 
response to IL-2 is much larger than to IL-15 (7). Mso, the 
proliferative response of human CD56  bright NK cells or anti- 
CD3-stimulated  lymphocytes to  IL-2  and  IL-15  are  dis- 
tinct  (7,  8).  It has been recently shown that the interaction 
of IL-15 with  IL-2R13/y is less  stable  than  is the  case for 
IL-2 (8).  In addition,  IL-2Ro~, which is able  to bind IL-2 
but not IL-15, negatively regulates peripheral expansion of 
T  lymphocytes  (9).  IL-15  and  IL-2  are  also  differentially 
produced.  The  highest  amounts  of IL-15 mRNA  are  ex- 
pressed  in  epithelial  and  fibroblast  cell lines,  whereas  it  is 
absent in activated peripheral  blood T  lymphocytes (1).  In 
contrast,  the only cells  known to produce IL-2 are T  cells 
(10). The functional differences between IL-15 and IL-2, as 
well as the production of these two cytokines by mutually 
exclusive cell types, might result in the preferential usage of 
one of these cytokines in a particular system. 
Whereas induction of proliferation and cytotoxic activity 
of peripheral  blood  T  lymphocytes  by  IL-15  has  been 
shown  (1,  3),  there  are presently no studies  that addressed 
the possible role of this cytokine in the differentiation ofT 
progenitor  cells  in  the  thymus.  Thymocytes  differentiate 
from progenitor  cells,  which  originate  from stem  cells  of 
the fetal liver or the adult bone marrow. It has been shown 
in several independent studies that, both in mice and in hu- 
nlans, bipotential T/NK  progenitor cells  are present in the 
thymus.  The  phenotype  of those  bipotential  T/NK  pro- 
genitors  has  been  defined  as  FcyRII/III+CD3  CD4 
CD8-CD25-CD44 + in the mouse (11-13) and as CD34  bright 
CDI-CD2-CD5  CD3-CD4  CD8  in humans (14).  From 
the  next  stage  of differentiation,  CD25+CD44 +  cells  in 
mice (15)  and CDI+CD2 + CD5 + cells in humans (14,  16), 
which  both  are  still  CD4-CD8-TCR-,  become  T  cell 
committed.  Subsequently,  these cells rearrange  their TCR 
genes and become CD4+CD8 + thymocytes expressing the 
CD3/TCR  complex. After negative and positive selection, 
they eventually become functionally mature CD4 or CD8 
single-positive  ceils  (SP)  that  emigrate  from  the  thymus. 
Although  bipotential  T/NK  progenitor  ceils  are  clearly 
present in the thymus, these cells preferentially differentiate 
in  this  lymphoid organ  into  T  cells,  whereas  extrathymi- 
cally, they mainly differentiate into NK cells (12,  14). This 
indicates  that the signals which are required by the  T/NK 
bipotential  progenitor  cells  to  differentiate  into  either  di- 
rection are different. 
In the murine fetal thymus, a substantial part of the pro- 
genitor cell population expresses the  13 chain of the IL-2R 
(this  study  and  reference  17),  as  well  as  IL-15Rcx  (this 
study),  which  probably  enables  these  cells  to  respond  to 
IL-2 as well as to IL-15. We therefore examined and com- 
pared the effects of IL-15 and IL-2 on the differentiation of 
these progenitor cells.  Our results show that there are im- 
portant differences between IL-15 and IL-2, and that IL-2R(x 
negatively regulates IL-2-induced cell expansion. 
Materials and Methods 
Mice.  BALB/c,  originally  purchased  from  Proefdierencen- 
trum (Catholic  University Leuven, Leuven, Belgium),  were bred 
in  our breeding facility.  To  obtain  dated  pregnant  mice,  mice 
were mated for 15 h and the fetuses were renmved at the indi- 
cated fetal days (FD) (plug date  =  day 0). 
Cytokines.  Purified  simian  rlL-15  and  human  rlL-2  were 
kindly  provided  by  Dr.  E.  Thomas  (Immunex  Corp.,  Seattle, 
WA) and Dr. M. Gately  (Hoffmann-La Roche, Nutley, NJ), re- 
spectively. In a 24-h CTLL-2 proliferation  assay, 500 ng/ml lL-15 
induced the same proliferation  as 1,000 U/ml IL-2. 
Antibodies, Flow Cytometric Analysis, and Sorting.  The mAbs used 
for staining,  flow cytometric analysis, and sorting were described 
before (18,  19). To avoid aspecific binding of mAbs,  the Fc3~R 
was blocked by preincubation of the cells with saturating amounts 
ofanti-Fo/RlI/III mAb (clone 2.4G2) for 15 rain at 4~  Fc'yR- 
blocking was not done when cells had to be labeled with FITC- 
conjugated  anti-Fc"/R  mAb  afterwards,  t}ropidium  iodide  was 
added to the cells (2 p.g/ml) just before analysis. Gating was done 
on propidium iodide-negative thymocytes to exclude dead cells. 
In the case of sorting of CD45-positive and -negative cells from 
FD17 thymus, thymic cell suspension  was prepared by trypsiniza- 
tion of the thymic lobes (20). This treatment does not remove the 
CD45 antigen front the cell surface (data not shown). 
The mAb used for the addition to fetal thymic organ culture 
(FTOC) was purified unlabeled anti-IL-2RoL (clone PC61) (kind 
gift of Dr. M. Nabholz, Epalinges,  Switzerland). 
Reverse Transcription (RT)-PCR and Southern Blotting.  Trisol 
(Life Technologies, Gaithersburg,  MD) was added to sorted cells 
and RNA was extracted according to the manufacturer's instruc- 
tions,  cDNA was synthesized  with oligo(dT) as primer using the 
Superscript  kit  (Life Technologies).  Oligonncleotides  used  for 
RT-PCR and hybridization were as described by Chun et at. (21) 
for recombination activating gene-1 (RAG-l). Other oligonucle- 
otides  used  were  as  follows:  for  IL-15:  AATGAAGTGCT- 
TTCTCTTGG  (sense primer),  GTGTTGATGAACATTTG- 
GAC (antisense primer),  and AACAGAATCTGGATGCAAAG 
(probe);  for  IL-2:  TGATGGACCTACAGGAGCTCCTGAG 
(sense primer),  GAGTCAAATCCAGAACATGCCGCAG (an- 
tisense primer),  and CACCTTCAAATTTTACTTGCCCAAG- 
CAGGCC (probe); for IL-15Rcc ATTGAGCATGCTGACAT- 
CCG (sense primer), TCTCTGTTATCCTGAGGGAG (antisense 
primer),  and GTAACTCTGGCTTTAAGCGG (probe);  and for 
hypoxanthin phosphoribosyltransferase  (HPRT):  GTAATGAT- 
CAGTCAACGGGGGAC (sense primer),  CCAGCAAGCTTG- 
CAACCTTAACCA (antisense  primer),  and GCTTTCCCTG- 
GTTAAGCAGTACAGCCCC (probe).  PCR amplification  was 
performed  using  a  96-well  thermocycler  (Ornnigene,  Hybaid 
Teddington, UK) with 30 (RAG-I, IL-15, IL-2, and HPRT) or 
33 cycles (IL-15Rot and HPRT) of 94~  for 0.5 min,  55~  fbr 
0.5  rain,  and 72~  for  1 nfin.  In each  PCR,  water and  50  ng 
mouse  genomic  DNA were  included  as  negative  controls.  All 
prinaer pairs amplified eDNA only. For semiquantitative  RT-PCR, 
four twofold (IL-15, IL-2, and HPRT) or threefold dilutions  (IL- 
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Southern blotting, PCR products were separated on 2% agarose 
gels, denaturated, and transferred onto Nytran paper (Schleicher 
& Schuell, Inc., Keene, NH). The DNA was UV-cross-linked to 
the membrane, probed with a 33p-labeled internal oligonucleotide, 
and the  membrane was  exposed to film (Amersham, Arlington 
Heights, IL). 
Cell-mediated CytotoxicityAssay.  YAC-1  cells  were  used  as 
target cells. Cytotoxicity was analyzed in a 6 h SlCr release assay 
using 1,000  target cells per well as described previously (22). 
FTOC.  Four to five thymic lobes from FD14 BALB/c mice 
were placed on the surface ofpolycarbonate filters (0.8-1~m pore 
size; Nuclepore, Pleasanton, CA) that were supported on blocks 
of gelfoam (Upjohn Co., Kalamazoo, MI) in  1.8 ml of Iscove's 
modified Dulbecco's medium supplemented with 10% FCS (both 
from Life Technologies) in 12-well plates. Cytokines were added 
at different concentrations, as indicated. In the case of IL-2Re~- 
blocking experiments, anti-IL-2Rc~ mAb was added at 100 I*g/ml. 
Cultures were grown in 7.5% CO 2 in humid air at 37~  for 11 d. 
Afterwards, the thymus lobes were disrupted using a small potter 
homogenizer. Cell viability was determined by trypan blue exclu- 
sion. 
Recolonization Assays.  Alymphoid lobes were prepared by cul- 
turing FD15 BALB/c thymic lobes in FTOC in the presence of 
1.35  mM  2'-deoxyguanosine (Sigma Chemical Co.,  Filter Ser- 
vice, Eupen,  Belgium) for 5  d.  After extensive washing,  single 
thymic lobes were put together with 1,000  sorted thymic cells in 
a total volume of 25 I.U in the wells ofa Terasaki plate. The plates 
were inverted to form hanging drops, and the cells were allowed 
to seed the lobes during 48  h.  Subsequently, untransferred cells 
were removed by washing, and the lobes were cultured in FTOC 
for 'the indicated time. No  thymocytes could be detected after 
FTOC of deoxyguanosine-treated thymic lobes that were not re- 
populated with thymic cells. 
Results 
Expression of lL-2R~8,  IL-2Roe,  and  IL-15Roe  on  thymo- 
cytes.  Freshly  prepared  thymocytes  from  FD15,  FD17, 
2-d-old, and adult mice were analyzed by flow cytometric 
analysis for the expression of IL-2R[3 and IL-2Rcx (Fig. 1). 
The cell number per thymus was 50,000,  750,000,  107 and 
108 for FD15, FD17, 2-d-old, and adult mice, respectively. 
Approximately 6% ofFD15 thymocytes expressed IL-2R[3. 
This  percentage  decreased  to  <1%  in  2-d-old  mice;  in 
adult mice, it was ~2%. Expression oflL-2RI3 and IL-2R~x 
was  almost,  but  not  completely,  mutually  exclusive.  In 
FD15 thymocytes, IL-21L[3-positive cells were bright posi- 
tive for Fc'yR and CD44, were mainly negative for TCReq3 
or TCR~/8,  and  HSA was  expressed at low levels or was 
absent.  This  indicates  that  IL-2R[3  is  expressed  on  thy- 
mocyte  progenitor  cells.  At  FDt7,  part  of the  IL-2RI3- 
positive cells became  negative  for  Fc3,R,  and  part  of the 
TCRyB  cells clearly expressed  IL-21L~.  In  adult  thymo- 
cytes, most IL-2R[3-positive cells were mainly FcyR nega- 
tive and TCRe~[3 positive. 
To examine expression of IL-15Req to which no antibody 
is available yet, we performed a semiquantitative RT-PCR. 
As a  control,  the housekeeping enzyme  HPRT  was  stud- 
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Figure 1.  Distribution of IL-2R[3 and IL-2Ret on thymocyte subsets  by flow cytometric analysis.  Thymocytes from FD15, FD17, 2-d-old and 2-mo-old 
mice were labeled with mAbs against the indicated antigens. Propidium iodide was added before analysis.  Dot plots are shown for propidium iodide-neg- 
ative thymocytes. Percentages of each population are represented in each quadrant. 
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RT-PCR analysis, mRNAs were prepared from unseparated or sorted 
IL-2RI3+CD8-TCRot[3-TCR~/B  -  cells from FD17 mice. The  expres- 
sion of IL-15Roe and HPRT mRNA was analyzed by semiquantitative 
RT-PCR and Southern blotting. For semiquantitative RT-PCR, four 
threefold dilutions of each cDNA sample were amplified. 
Figure  3.  R.AG-1 expression 
in  fetal thymic  IL-2PqB  +  cells. 
mRNAs were prepared from un- 
separated thymocytes from adult 
mice  or  from  sorted IL-2R.IB  + 
CD8-  TCR.cq~-  TCP,.-/8  -  cells 
from  uncultured  FD16 thymic 
lobes, mRNA was analyzed by 
Iq,  T-PCR and Southern blotting 
for the expression of RAG-1 and 
HPRT. 
ied.  The results show that an equivalent amount of HPRT 
mRNA  was  present  in  the  populations  tested.  IL-15Re~ 
mKNA  was  abundantly  present  in  FD17  thymus,  both 
in  the  total  cell  population  and  in  IL-2R.13+CD8  - 
TCRet~-TCRy8-  sorted cells  (Fig. 2). 
Differential Capacity of IL-2R~8-positive  Fetal Thymocytes to 
Differentiate into T  Cells in  a  Thymic  Environment  and  into 
Functional NK Cells in Cell Suspension in the Presence of lL-I S. 
To examine  whether  IL-2R[3+TCR  -  cells were  commit- 
ted to the T  cell lineage,  we first tested  if these  cells  con- 
tained  RAG-1  mRNA.  RT-PCR  was  performed  using 
RAG-l-specific  oligonucleotides.  As  a  positive  control, 
uncultured  and  unseparated  thymocytes  from  adult  mice 
were  used.  Fig.  3  shows  that  uncultured,  sorted  IL- 
2R[3+CD8-TCRot~-TCR~/8 -  cells  from FD16 thymuses 
did not express RAG-1  mRNA.  This indicates  that either 
these  cells  are not T  progenitor cells  or that these  cells  do 
not yet contain RAG-1  mRNA.  Therefore, we examined 
if these  cells had the potential  to differentiate  into  T  ceils. 
For  this  purpose,  highly  purified  IL-2R[3+CD8-TCR  - 
cells  (>99.5% purity)  from FD15 or FD16 thymuses were 
transferred to alymphoid thymic lobes (1,000 cells per lobe) 
and analyzed after FTOC for 6 and 12 d. It is shown in Fig. 4 
that CD4 and CD8 double positive (DP)  cells  were clearly 
present  after 6  d,  as were  TCR0~  cells  with  intermediate 
TCR  density and TCRy8  cells.  After 12 d  of FTOC,  the 
percentage of CD4 and CD8 SP cells  and of cells with high 
TCRot[3  density was increased.  The  absolute  cell  number 
per lobe was 20,000 and 30,000 after 6 and 12 d of FTOC, 
respectively.  Thymic lobes  that did not receive  sorted  IL- 
2R~ + thymocytes did not contain thymocytes after FTOC 
(data not shown). 
Alternatively,  unsorted  FD16  thymocytes or sorted  IL- 
2RIB+CD8-TCR  cells  from  FD16  thymuses  were  cul- 
tured  in  cell  suspension  in  the  presence  of IL-15 for 5  d. 
There  was  a  2.5-fold increase  in  the  cell  number  of total 
FD16 thymic cells  and a  12-fold increase in the  cell num- 
ber of sorted IL-2R~+CD8-TCR  -  cells  (data not shown). 
No TCRo~[3  +  or TCRy8 +  cells  were  present  after  IL-15 
culture  of the sorted IL-2R~+CD8-TCR -  cells  (data not 
shown). The resulting cells  were very efficient in lysing the 
NK-susceptible  target  cell  line  YAC-1.  Freshly  prepared 
uncultured  cells  did  not  kill  YAC-1  cells  to  a  significant 
extent  (Fig.  5).  No viable cells were left when FD16 thy- 
mic cells  were cultured in the absence of exogenous IL-15 
for 5 d  (data not shown). 
Differential Expression of IL-15 and  IL-2  in  the  Thymus. 
An RT-PCR  was performed to study expression  of IL-15 
mRNA  in fetal and adult thymus. It is shown in Fig. 6 that 
1L-15  mRNA  is  clearly  expressed  in  the  thymus  of fetal 
and adult  mice.  To  examine which  cell population  of the 
thymus mainly expressed  IL-15 mRNA,  two types of ex- 
periments were done. In the first, FD15 thymic lobes were 
organ  cultured  in  the  presence  of deoxyguanosine,  which 
results in depletion of thymocytes and stromal cells  of bone 
marrow origin. The majority of  the cells that are still present 
after  this  treatment  are  epithelial  stromal  cells.  Deoxygua- 
nosine-treated thymic lobes clearly expressed IL-15 mRNA. 
In  a  second  type  of experiment,  a  semiquantitative  RT- 
PCR  was done on total as well as on CD45 + and CD45- 
sorted cells  from trypsinized FD17 thymic lobes.  The con- 
trol RT-PCR  on HPRT  showed that equivalent amounts 
of RNA were present in all three preparations. With regard 
to IL-15 mRNA expression, only low amounts were found 
in  CD45 +  cells,  which  contain  thymocytes  and  stromal 
cells  of bone marrow origin.  CD45-  cells,  which are  epi- 
thelial stromal cells,  expressed high levels of IL-15 mRNA. 
As  a  control,  we  also  analyzed  the  expression  of  IL-2 
mRNA  in the same preparations.  As expected,  and in con- 
trast  to  IL-15 mRNA  expression,  IL-2 mRNA  could not 
be  detected  in  deoxyguanosine-treated  thymic lobes  or in 
CD45- sorted cells,  but was present in CD45 + sorted cells. 
Treatment of FTOC with IL-15 or IL-2.  To  study  the 
effect  of exogenous  IL-15  on  intrathymic  differentiation, 
FD14  thymic  lobes  were  cultured  in  FTOC  in  the  pres- 
ence of 20,  100,  or 500 ng/ml IL-15 or 40,  200,  or  1,000 
U/ml  IL-2 for  11  d.  In a  CTLL-2 proliferation  assay,  the 
activity of 500 ng/ml IL-15 was comparable with 1,000 U/ml 
IL-2 (data not shown). After 11  d of FTOC, the cell num- 
ber per  thymic lobe  was  increased  more  than  twofold  in 
the  presence  of 20  or  100  ng/ml  IL-15,  and  fourfold  in 
cultures with 500 ng/ml IL-15, as compared to the control 
culture  (Table  1).  Notwithstanding  the  considerable  cell 
expansion in FTOC with 20 ng/ml IL-15, the percentages 
of the  different subpopulations  with  regard to CD4 versus 
CD8,  IL-2R~x  versus  IL-2R[3,  and  TCRo~[3  expression 
were  not  drastically  changed,  showing  that  all  these  sub- 
populations  increased  in  absolute  cell  number.  The  per- 
centage  of TCRy8  cells,  both  Vy3  +  and  Vy3-,  doubled. 
This  showed  that  the  increase  in  the  number  of TCR',/8 
cells  is higher than that of the other thymocyte subpopula- 
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Figure  4.  Fetal  thymic IL-2RI3  + cells differenti- 
ate  into  T  cells  in  FTOC.  IL-2P43+CD8  -- 
TCRcx[3 TCR'y8  cells  were sorted from FD16 
thymic lobes and transferred to  deoxyguanosine- 
treated thymic lobes. After FTOC for 6 and 12 d, 
cells were analyzed. Results shown are representa- 
tive of two independent experiments. 
tions. In the presence of 100 ng/ml IL-15, the percentages 
ofCD4+CD8  -  and CD4+CD8  + cells were only half of those 
of the control culture. Also, the TCRoL~  l~  and TCRcII3  high 
subpopulations were reduced to a similar extent. Given the 
increase in ceil number per lobe in this culture condition, 
however, there was no change in absolute cell numbers of 
these  subpopulations. A  strong increase was  found in cell 
numbers of TCRy8  thymocytes and of ceils with an im- 
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Figure  5.  Fetal  thymic IL-2ILI3  + cells cultured in cell suspension  in the 
presence of IL-15 generate functional NK  cells. Total  or  IL-2P,.13  + 
CD8-TCRet[3-TCR',/8-  sorted FD16 thymic cells were cultured in cell 
suspension in the presence of 500 ng/ml IL-15 for 5 d or were used un- 
cultured. Lytic activity  was tested against the NK-sensitive  target cell line 
YAC-1. Results shown are representative of two independent experi- 
menU. 
mature phenotype: CD4-CD8-  IL2RI3+Fc~/R+TCR  -. In 
FTOC with 500 ng/ml IL-15, almost no CD4+CD8 -  and 
CD4+CD8 + cells were present, and no significant number 
ofTCP,  ot~  l~  or TCR.ot~  high ceils could be detected. 8% of 
the  cells  were  CD4-CD8 +,  but  these  ceils  mainly  ex- 
pressed  CDtomt  instead of CD8ot[B.  The  cell  number of 
TCRy8 ceils, mainly V~/3 +, increased significantly (Fig. 7). 
The CD8omt + ceils were predominantly TCRy8 ceils (data 
not shown).  The majority of the  cells had a  CD4- CDt- 
IL-2RI3+FcyR+TCR  -  phenotype. No Ig  + cells could be 
detected  (data  not  shown),  indicating that  there  was  no 
outgrowth orb  cells. 
In contrast to  IL-15-treated FTOCs,  cultures with 40, 
200,  or  1,000  U/ml  IL-2  did  not result in a  higher  cell 
yield, as compared to the  control culture (Table 1).  With 
regard to phenotype, culture in the presence of 40 or 200 
U/ml  IL-2  resulted  in  a  small  increase  of  IL-2Rcx  +- 
IL-2R[3 +  cells  and  of FcyR  +  cells.  The  cell  number of 
TCRot~  high cells decreased.  There was  no increase in the 
cell number of TCRy8  cells.  Cultures with  1,000  U/ml 
IL-2 yielded essentially the same phenotype as did FTOC 
with  500  ng/ml IL-15.  A  small difference was  that  there 
was always a tendancy in IL-2-treated cultures for a higher 
percentage oflL-2Rix  + ceils (Fig. 7). 
Blocking IL-2Ra Drastically Increases the Cell Number in IL-2- 
treated FTOC.  A surprising finding was that FTOC treated 
with  different concentrations of IL-2 never yielded more 
cells  than  control  cultures,  whereas  IL-15  treatment  re- 
sulted in a two- to fourfold increase in cell number (Table 
1). Since IL-2, but not IL-15, is able to bind to the ot chain 
of the  IL-2R, we  added  anti-IL-2Rix mAb to  IL-2-sup- 
plemented FTOC. The cell number of these cultures was 
increased more  than  twofold  compared  to  FTOC  in the 
presence of IL-2 only. The phenotype of the resulting ceils 
was not drastically changed by addition of the anti-IL-2Ro~ 
l'nAb (Fig. 8). 
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mRNA  expression in  thymus. 
(Left) IL-15, IL-2, and  HPRT 
mlKNA expression analyzed  with 
IKT-PCIK and Southern blotting 
in total thymic cells from FD18 
or adult mice or in  deoxygua- 
nosine-treated  FD15  thymic 
lobes. (Right) IL-15, IL-2, and 
HP1KT mlKNA expression ana- 
lyzed with semiquantitative RT- 
PCIK and  Southern blotting in 
total, CD45  +, or CD45-  sorted 
cells from the FD17 thymus. For 
semiquantitative IKT-PC1K, four 
twofold dilutions of each cDNA 
sample were amplified. 
Cells from  FTOC  with Exogenous  IL-15 Have Lost  T  Pro- 
genitor Potential.  Given that FTOC  with  high  concentra- 
tions  of  exogenous  IL-15  yielded  mainly  CD4-CD8- 
CD25+/-IL21K13+FcylK+TC1K -  cells,  which are cells  with 
an immature phenotype, we examined whether these cells 
could still  differentiate  into  T  cells.  Sorted  CD44 + CD8- 
TCR-  cells from FTOCs were transferred to deoxyguano- 
sine-treated  thymic lobes and organ cultured.  Fig. 9  shows 
the phenotypic analysis of a representative  experiment after 
9  d  culture.  Sorted cells from control FTOC differentiated 
into T  cells,  as shown by the appearance of CD44-CD25 + 
and  CD44-CD25-  cells  in  the  CD8-TCR.cx13-TCR.yS- 
population,  and by the  generation  of CD4+CD8 +  and SP 
cells.  On  the  contrary,  similarly  sorted  cells  from  IL-15 
FTOC  did  not  differentiate  into  the  T  lineage:  they  re- 
mained  CD44  positive  and  CD4-CD8  double  negative. 
The  same  results  were  obtained  when  the  organ  cultures 
were analyzed after 16 d  (data not shown). 
Addition  of lL-15  to  FTOC  Shifts  Differentiation  towards 
Functional  NK  Cells.  Since CD44+CD8ot-TCR -  cells iso- 
Table 1.  Effect  of Exogenous IL-15 and IL-2 on Cell  Yield of 
Organ-cultured FD 14  Thymic Lobes 
Cytokine added  Cells per lobe 
None  282 -4- 45* 
IL-15 
20 ng/ml  738  -+ 172 
100 ng/ml  636 -+ 46 
500 ng/ml  1,132  -4- 226 
IL-2 
40 U/ml  285  -+ 73 
200 U/rnl  313 +  20 
1000 U/ml  250  +  16 
*Data are the mean cell number (￿  103) per thymic lobe +SD of three 
to six experiments. 
lated from IL-15-supplemented FTOC did not have any T 
cell  progenitor  potential,  we  examined  if these  cells  had 
lytic  activity.  CD44+CD8-TCR -  cells  were  sorted  from 
IL-15-supplemented FTOC and tested in a 51Cr release as- 
say.  Fig.  10  shows that  these  cells  killed  the  NK-sensitive 
YAC-1 target cell line very efficiently. Similarly sorted cells 
from control FTOC  did not have  any significant lytic ac- 
tivity. 
Discussion 
IL-15 and  IL-2 both  require  the  13  and  ~/  chain  of the 
IL-2P, for binding and signal transduction  (3).  This proba- 
bly explains  why several biological activities  of those  two 
cytokines are similar (1, 5-7). However, IL-15 and IL-2 are 
produced by mutually exclusive cell types (1,  10).  In addi- 
tion, only IL-2 is able to bind to IL-2RoL (3),  whereas only 
IL-15  is  able  to  bind  to  IL-15RIx  (4).  This  indicates  that 
there may be functional differences between those two cy- 
tokines.  We  have  therefore  examined  and  compared  the 
effects oflL-15 and IL-2 on differentiation ofthymic bipo- 
tential T/NK progenitor cells towards T  cells  and NK cells. 
In contrast  to T  cells,  NK  cells  do  not rearrange  TCR 
genes and develop normally in SCID mice (23) and RAG- 
deficient mice (24, 25). Nevertheless, there are several sim- 
ilarities  between  T  and NK  cells.  These  include  cytoplas- 
mic  expression  of CD3  proteins  (26,  27),  cell  membrane 
expression  of numerous  cell  surface  antigens  (reviewed  in 
28), and cytolytic activity. These phenotypic and functional 
similarities between T  and NK cells  indicate that these two 
lymphocyte subsets are related. Additional evidence for this 
has recently been obtained by the finding that both in mice 
and in humans,  T  and NK cells  originate from a common 
precursor that is present in the thymus (12-14, 29, 30). Al- 
though the existence  ofbipotential T/NK  progenitors im- 
plicates  a  direct  lineage  relationship  between  T  and  NK 
cells,  the anatomical localizations for T  and NK differentia- 
tion  are  not  the  same.  The  thymus  is  required  for main- 
stream  T  cell  development.  Both  thymic  epithelial  and 
mesenchymal cells are necessary for early differentiation  of 
progenitor cells  towards DP thymocytes (20), whereas thy- 
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ng/ml IL-15 or 40, 200, or 1,000 U/ml IL-2 for 11 d. Cells were labeled with mAbs  against the indicated antigens. Propidium iodide was added before 
analysis and propidium iodide-negative thymocytes were gated. Results shown are representative of three to six independent experiments. 
mic epithelial cells provide unique signals for positive selec- 
tion  of DP  thymocytes  towards  mature  T  lymphocytes 
(31).  In contrast to T  ceil differentiation, NK cell differen- 
tiation clearly does not require the thymus,  since athymic 
nude mice have normal numbers of NK cells. It is generally 
accepted that the bone marrow is one of the main sites for 
NK cell development (32, 33). 
In the mouse,  Rodewald et al. have shown  that the bi- 
potential T/NK  progenitors in  the  fetal thymus  are  con- 
tained  in  the  Fc~/R  +  population  (12).  This  population, 
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which  has  a  CD3-CD4-CD8-CD25-CD44+HSA  -/l~ 
phenotype (13), is abundantly present during fetal life (12). 
It is shown  in  this report that  "-~6% of FD15  thymocytes 
expressed IL-2R[3 and that the majority of these cells had 
a  progenitor-like  phenotype,  i.e.,  Fc'yR  +  and  CD25- 
CD44+HSA-/l~  -.  All  IL-2R[3 +  ceils  coexpressed 
Fc-/R, but the IL-2R[3 + population (6% of total cell num- 
ber)  was  only a  fraction of the  Fc~/R  +  population  (26%). 
IL-2RI3+CD8-TCRotl3-TCR~/8 -  cells are not yet in the 
process of TCR  rearrangement,  since no RAG-1  mRNA CONTROL 
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Figure 8.  Blocking  IL-2Rc~ drastically  increases the cell number in IL-2-treated FTOC. FDI4 thymic lobes were organ-cultured  without the addition 
of cytokines or antibodies,  with t,000 U/ml IL-2, with 100 Ixg/ml  anti-lL-2Rc* mAb, or with IL-2 plus anti-IL-2R~x  mAb for 11 d. Cells  were labeled 
with mAbs against  the indicated  antigens.  Propidiuna  iodide was added before analysis,  and propidinm iodide-negative  thymocytes  were gated. Results 
shown are representative  of two independent experiments. 
could be detected. Upon transfer to deoxyguanosine-treated 
thymic  lobes,  highly  purified  IL-2R[3+CD8-TCRot~  - 
TCRyB-  cells  differentiated  into  TCRcl[3  and  TCRyB 
cells,  showing that  these  cells  were  indeed T  progenitor 
cells. These results are in agreement with those ofFalk et al. 
(17).  Purified IL-2RI3+CD8-TCRot[3-TCR3,8  -  cells also 
CD44  CD4 
FTOC 
CONTROL 
FTOC 
11.-15 
.~  CD25 
i'i{l  0 
CD8 
Figure 9.  FTOC in the presence oflL-I5 results in loss ofT progeni- 
tor cells.. F1)14 thymic lobes were organ-cultured  without or with IL-15 
(500 ng/ml) for 11 d. Subsequently,  CD44+CD8-TCR(x~-TCR'/8 - cells 
were sorted and  transferred to  deoxyguanosine-treated FD15 thymic 
lobes. Cells were analyzed  after FTOC for 9 d. Cells shown in the CD44 
versus CD25 dot plots were gated on CD8-TCR~xl3 TCR3,8-  cells. 
Results shown are representative  of two independent experiments. 
expressed IL-15R& mRNA, indicating that these  cells are 
able  to  respond to  1L-15.  Indeed,  these  cells proliferated 
extensively when cultured in cell suspension in the  pres- 
ence of lL-15 and, more importantly, in this culture condi- 
tion,  they differentiated into functional NK ceils.  Freshly 
sorted  IL-2R[3 +  thymic  ceils  did  not  have  NK  activity. 
These findings indicate that  IL-2R[3  +  cells present in the 
fetal thymus contain progenitors for both T  and NK cells. 
It still has to be determined whether IL-2R[3 + cells are in- 
deed bipotential T/NK  cells or whether the IL-2R{3  + cell 
population contains both T  and NK progenitors. 
Although bipotential progenitor cells can develop into T 
cells as well as NK cells, T  cell differentiation mainly occurs 
in the thymus, whereas NK cell differentiation mainly oc- 
curs  extrathymically. This  indicates that  cell-cell interac- 
tions and/or cytokines that direct these bipotential progen- 
itor cells towards T  or NK cell differentiation pathways are 
different. A  central role for cytokines in the development 
of both T  and NK cells has recently been demonstrated by 
the generation of mice deficient for the "y chain of the [L-2R, 
since no T  or NK cells develop in these mice (34).  Also in 
humans, mutations in the gene encoding the IL-2R'y chain 
results in a  severe block in T  and NK development (35). 
The ",/chain of the IL-2R is shared by IL-4R, IL-7R, IL-9R, 
and  IL-15R  (3,  36-39).  Previously, it  was  proposed  that 
IL-2 has a  crucial role in thymic development. However, 
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IL-2  knockout  mice  have  normal  thymic  development 
(40).  Also,  IL-4 as well as  IL-2 plus  IL-4 knockout mice 
have normal numbers  of functional  T  cells  (41,  42).  Re- 
cently,  IL-2R[B-deficient mice  have been  described  (43). 
Although not addressed in this study, cells from these mice 
can be considered to be IL-15 unresponsive.  The thymus 
from these  mice  reveals normal phenotypic  features with 
regard to CD4-CD8 subpopulations up to 3 wk of age. In 
6-wk-old mice, thymocyte cell numbers are decreased sev- 
enfold with a drastic reduction of DN and DP thymocyte 
subpopulations. As peripheral T  cells are spontaneously ac- 
tivated  and  autoimmunity  develops  in  these  mice,  how- 
ever,  the  observed reduction  in  thymocyte  cell  numbers 
was interpreted by the authors as being the result of general 
stress-induced changes rather than intrinsic  problems with 
thymocyte  development  (43).  The  only  cytokine  with  a 
crucial role in T  cell development that has been described 
so far is IL-7. This has been demonstrated by generation of 
mice deficient for IL-7 (44)  or deficient for the {x chain of 
the IL-7R (45).  Also, by the use of neutralizing anti-IL-7 
mAbs,  it  has been  demonstrated  that  IL-7 plays a  central 
role in thymic development (46,  47). 
Whereas IL-7 is an important cytokine for T  cell differ- 
entiation,  the  crucial  cytokines for NK cell development 
probably are  IL-2 and/or  IL-15. This has been shown by 
postnatal treatment of mice with anti-IL-2R[3 mAb, which 
results in long-term elimination of NK cells  (48).  NK cell 
activity is  also  markedly reduced  in  IL-2-deficient mice, 
but  is  still  inducible  (49).  IL-15-deficient mice  have  not 
been described so far, but IL-15 has been demonstrated to 
induce activation and proliferation of human NK cells  (7), 
indicating a potential role of this cytokine in NK cell de- 
velopment and function. 
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It is shown here that both IL-15 and IL-2 mRNA is ex- 
pressed  in  fetal  and  adult  thymuses.  IL-15  mRNA  was 
mainly present in CD45- cells, which are stromal epithelial 
cells.  IL-2 mRNA was found exclusively in CD45 + cells. 
This  is  in  agreement with  previous  reports  showing  that 
IL-15 is abundantly present in epithelial and fibroblast cell 
lines, but not in peripheral blood T lymphocytes (1), whereas 
the  only cells  that are known to produce  IL-2 are T  cells 
(10).  Since it is shown in this report that IL-2R[3 as well as 
IL-15R{x  are  expressed  by bipotential  T/NK  progenitor 
cells in the murine thymus, we examined whether addition 
oflL-15 to FTOC would have an effect on the choice that 
these progenitor cells make to differentiate in the direction 
of either T  or NK ceils. Since others have shown that there 
are some functional differences oflL-15 and IL-2 (7-9), we 
compared the effect of IL-15 addition to FTOC with that 
of IL-2. Addition of low concentrations of IL-15 to FTOC 
resulted in a 2.5-fold increase in total cell number, as com- 
pared to control cultures. All differentiation stages were ex- 
panded  including  TCR-negative,  TCR{x[3,  and  TCR~/8 
cells.  This could be either a direct effect oflL-15 or an in- 
direct  effect  caused  by  secondary  cytokine  production. 
FTOC in the presence of high concentrations of IL-15 re- 
suited in a four times higher cell yield than conu:ol cultures. 
Differentiation  towards  TCRot[B  ceils  did  not  occur, 
whereas TCR~/8 cells still  developed. The majority of the 
cells were IL-2RJ3+CD44+CD25+/-TCR -. Blocking IL- 
2R[3 with mAb neutralized the effects of IL-15 on FTOC; 
blocking IL-2R0t had  no  effect (data not  shown).  As  the 
homogenous population  of CD44+TCR -  cells  in  IL-15- 
treated FTOC could be T  cell progenitors, we transferred 
these  cells  to  alymphoid thymic lobes  and  followed their 
differentiation.  No T  cell development could be detected. 
Contrary  to  the  absence  of T  cell  progenitor  potential, 
these cells were functional NK cells, as shown in a SlCr re- 
lease assay. Also, the finding that these cells only expressed 
Fc~/RIII (data not shown) indicates that these cells were in- 
deed  NK cells,  since  progenitor T  cells  express both  Fc- 
"/Rill and Fc~/RII (12).  Collectively, our findings indicate 
that IL-2RJ3  + cells in the fetal thymus are bipotential T/NK 
progenitor cells, and that addition of high amounts of IL-15 
to FTOC directs differentiation towards the NK pathway. 
We also  added  IL-2 to  FTOC.  The main difference as 
compared to IL-15-treated FTOC was that no increase in 
cell number was obtained with any tested concentration of 
IL-2. With regard to the receptor chains that interact with 
IL-15 and IL-2, both IL-2R[3 and IL-2R',/are required for 
the biological activity of these two cytokines (3). Only IL-2, 
however, is able to bind IL-2Rot (3), whereas only IL-15 is 
able to bind IL-15Rot (4). In addition, by the generation of 
IL-2Rot-deficient mice,  has  it  been  shown  recently  that 
IL-2Rot  negatively  regulates  peripheral  expansion  of  T 
lymphocytes (9). This prompted us to examine the effect of 
blocking IL-2Rot in  IL-2-treated FTOC.  The  result was 
that the cell number increased 2.5-fold. This strongly indi- 
cates that the lower cell number obtained in IL-2-treated 
FTOC versus  IL-15-treated FTOC  is caused by negative 
regulatory signals  delivered by IL-2Roc In early fetal thymuses, IL-2R[3 + cells  were mainly pro- 
genitor  cells.  From  FD16-17,  part  of IL-2R~-expressing 
cells were TCRy8 cells.  We have shown earlier that imma- 
ture TCRy8 thymocytes, as defined by expression of HSA, 
are  present  from  FD14,  whereas  mature,  HSA  negative, 
TCRy8  thymocytes appear  from FD16  (50).  During  this 
transition  from  the  immature  to  the  mature  phenotype, 
TCRy8  cells  start  to  express  IL-2R[3  (19).  It  has  been 
shown by others that IL-2R[~ is an activation marker, since 
it is expressed on thymocytes after TCR  ligation  (51,  52). 
This indicates that mature, but not immature, fetal TCRy8 
cells  become activated in the thymus.  This is supported by 
the finding that in addition to expression of IL-2RI3, other 
cell  surface  markers  that  are  characteristic  for stimulation, 
such as FcyR and the B220 marker, become expressed dur- 
ing the transition from immature to mature fetal TCRy8 cells 
(22).  As mature  TCRy8  cells  express  IL-2Ri  3,  it  was not 
surprising that an extensive proliferation of these  cells  was 
observed  in  FTOC  supplemented  with  IL-15.  Immature 
TCRy8  thymocytes did not expand to a significant extent 
(data not shown). Another difference between the effects of 
IL-15 and IL-2 in FTOC was that no or only a low expan- 
sion of TCRy8  cells  was observed in IL-2-treated FTOC. 
Our  results  showing  that  exogenous  addition  of  low 
amounts  of IL-15,  but  not  IL-2,  induced  expansion  of 
TCRy8 ceils,  which were mainly TCR V~/3 cells,  is in line 
with  reports  showing  that  in  utero  treatment  with  anti- 
IL-2R[3 mAb completely abrogates development of Vy3  + 
dendritic epidermal cells  (53), which are the progeny of fe- 
tal  TCR  Vy3  thymocytes  (54),  whereas  IL-2-deficient 
mice  still  have  Vy3 +  dendritic  epidermal  cells  (55).  This 
indicates  a  potential  role  for  endogenous  IL-15  in  TCR 
Vy3 ceil  development  and/or  peripheral  expansion.  Also, 
proliferation of other TCRy8 cells during salmonella infec- 
tion, as well as the activation oflFN-y production by these 
y8 T  cells, has been shown to be mainly caused by IL-15 (56). 
In summary, we have compared the effects oflL-15 and 
IL-2  on  the  differentiation  of thymic  bipotential  T/NK 
progenitor cells  towards  TCRe~[3,  TCRyS,  and NK cells. 
It is shown that there  are important  functional  differences 
between those two cytokines. It can be hypothesized from 
these results that IL-15 is an important cytokine in the de- 
velopment of TCRy8  cells and NK cells. 
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